223 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
that satisfy our selection criteria; the impact of cyber security incidents, including the risks from the unauthorized access, interruption, failure
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
criteria; the impact of cyber security incidents, including the risks from the unauthorized access, interruption, failure or compromise of our information
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
visits and audits. The notice will include a statement concerning the intended scope of the audit and a list of the required documents or access
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
access, interruption, failure or compromise of our information systems or those of our business partners, collaborators or other third parties … Growth
PROPRIETARY AND CONFIDENTIAL New Survey Findings Underscore Importance of Naloxone Access (n=1,005 survey )1 Approximately 90% of respondents
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
26 Apr 24
Departure of Directors or Certain Officers
4:30pm
household, and financial or legal representatives or advisers who reasonably need to have access to such information to provide services to you, provided
8-K
EX-99.1
tpiyyksa0ybtlj
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
nsenpqrx0o4q9sgsc
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.2
afgjfhrlzv4 zq
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
4h6 hrl7u
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
EX-10.1
hmvi0go370exwq
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
EX-99.2
cn14duep78va3yx27
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
vca2dr1 ge
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.2
857j 0fdf
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.1
3b39ov1i
30 Aug 23
Other Events
6:30am